Napsin A staining in adrenal cortical neoplasms

Archives of Pathology and Laboratory Medicine

Volumn 137, Issue 7, 2013, Pages 883-

  Ballard, Morgan ^a   Sangoi, Ankur ^b   McKenney, Jesse ^c   Troxell, Megan ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b EL CAMINO HOSPITAL   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

ADENOCARCINOMA; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; SMALL CELL CARCINOMA;

ADENOCARCINOMA; ASPARTIC ACID ENDOPEPTIDASES; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; HUMANS; LUNG NEOPLASMS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 84879675799     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2012-0583-LE     Document Type: Letter

References (6)

1. Turner BM, Cagle PT, Sainz IM, Fukuoka J, Shen SS, Jagirdar J. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray. Arch Pathol Lab Med. 2012; 136(2):163-171.
2. Suzuki A, Shijubo N, Yamada G, et al. Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs. Pathol Res Pract. 2005;201(8-9):579-586.
3. Bishop JA, Sharma R, Illei PB. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol. 2010;41(1):20-25.
4. Kadivar M, Boozari B. Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs [published online ahead of print August 20, 2012]. Appl Immunohistochem Mol Morphol. PMID: 22914608
5. Mukhopadhyay S, Katzenstein AL. Comparison of monoclonal Napsin A, polyclonal Napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas. Am J Clin Pathol. 2012;138(5): 703-711.
6. Ye J, Findeis-Hosey JJ, Yang Q, et al. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Appl Immunohistochem Mol Morphol. 2011; 19(4):313-317.